Shares of the European drugmaker Galapagos are soaring after Gilead Sciences said over the weekend that it would spend $5 billion on a collaboration ...
View full coverage on Google NewsGilead Sciences Skips Megamerger, Signs Deal With Galapagos - Barron's
Read More
Bagikan Berita Ini
Related Posts :
Stocks close little changed amid lingering trade tension The Dow Jones Industrial Average gave up a - msnNOW- Flavored vape ban: Will regulations stop vapers? - Vox.com
- Wall Street mixed as Microsoft climbs and Apple dips - Reuters
- Drugmaker halts shipments of ranitidine heartburn medication after contaminant found - CNN
- US existing home sales rise to 17-month high in August - CNBC
0 Response to "Gilead Sciences Skips Megamerger, Signs Deal With Galapagos - Barron's"
Post a Comment